{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:44Z","timestamp":1786119344744,"version":"build-2736575974"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/bor.0b013e328333b9e2","type":"journal-article","created":{"date-parts":[[2009,11,22]],"date-time":"2009-11-22T03:26:20Z","timestamp":1258860380000},"page":"78-84","source":"Crossref","is-referenced-by-count":17,"title":["Rheumatic manifestations of skin disease"],"prefix":"10.1097","volume":"22","author":[{"given":"Jennie T","family":"Clarke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria P","family":"Werth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"R2-14-20210128","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.autrev.2005.01.003","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"4","author":"Werth","year":"2005","journal-title":"J Autoimmun"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1191\/0961203304lu2020oa","article-title":"Dermatology position paper on the revision of the 1982 ACR criteria for SLE","volume":"13","author":"Albrecht","year":"2004","journal-title":"Lupus"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2133.1996.d01-1004.x","article-title":"Cutaneous manifestations of systemic lupus erythematosus","volume":"135","author":"Yell","year":"1996","journal-title":"Br J Dermatol"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous LE Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J Invest Dermatol"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2007.07826.x","article-title":"Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy","volume":"156","author":"Kreuter","year":"2007","journal-title":"Br J Dermatol"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/archdermatol.2008.582","article-title":"Clinically relevant information about cutaneous lupus erythematosus","volume":"145","author":"Callen","year":"2009","journal-title":"Arch Dermatol"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jaad.2008.11.882","article-title":"Discoid lupus erythematosus presenting with cysts, comedones, and cicatricial alopecia on the scalp","volume":"60","author":"Hemmati","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"31649","DOI":"10.1074\/jbc.M806155200","article-title":"The TREX1 double-stranded DNA degradation activity is defective in dominant mutations associated with autoimmune disease","volume":"283","author":"Lehtinen","year":"2008","journal-title":"J Biol Chem"},{"key":"R11-14-20210128","first-page":"376","article-title":"Oral lesions in lupus erythematosus: correlation with cutaneous lesions","volume":"18","author":"Nico","year":"2008","journal-title":"Eur J Dermatol"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/0961203309103052","article-title":"Ultraviolet light output of compact fluorescent lamps: comparison to conventional incandescent and halogen residential lighting sources","volume":"18","author":"Nuzum-Keim","year":"2009","journal-title":"Lupus"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/j.1751-1097.2009.00540.x","article-title":"Analysis of compact fluorescent lights for use by patients with photosensitive conditions","volume":"85","author":"Klein","year":"2009","journal-title":"Photochem Photobiol"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00403-008-0890-x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation","volume":"301","author":"Sontheimer","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"R15-14-20210128","first-page":"173","article-title":"The CLASI is a useful clinical instrument to separately follow activity and damage during therapy of cutaneous lupus erythematosus","volume":"144","author":"Bonilla-Martinez","year":"2008","journal-title":"Arch Dermatol"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/art.23319","article-title":"The Cutaneous Lupus Erythematosus Disease Activity and Severity index (CLASI) expansion for rheumatology and dermatology","volume":"59","author":"Krathen","year":"2008","journal-title":"Arthr Care Res"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.autrev.2009.02.022","article-title":"Development of a Core Set Questionnaire by the European Society of Cutaneous Lupus Erythematosus (EUSCLE)","volume":"8","author":"Kuhn","year":"2009","journal-title":"Autoimmun Rev"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archdermatol.2009.21","article-title":"Incidence of cutaneous lupus erythematosus, 1965\u20132005: a population-based study","volume":"145","author":"Durosaro","year":"2009","journal-title":"Arch Dermatol"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archdermatol.2008.594","article-title":"Cross-sectional analysis of a collaborative web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients","volume":"145","author":"Moghadam-Kia","year":"2009","journal-title":"Arch Dermatol"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0961203307087403","article-title":"Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations","volume":"17","author":"Koskenmies","year":"2008","journal-title":"Lupus"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2340\/00015555-0473","article-title":"Clinical follow-up of 102 anti-Ro\/SSA-positive patients with dermatological manifestations","volume":"88","author":"Popovic","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1525-1470.2008.00625.x","article-title":"Discoid lupus erythematosus in children: a retrospective study of 34 patients","volume":"25","author":"Sampaio","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1600-0781.2008.00373.x","article-title":"Photoprotective behaviour and sunscreen use: impact on vitamin D levels in cutaneous lupus erythematosus","volume":"24","author":"Cusack","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00228-007-0421-2","article-title":"Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation","volume":"64","author":"Tzellos","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archdermatol.2008.592","article-title":"Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking","volume":"145","author":"Kreuter","year":"2009","journal-title":"Arch Dermatol"},{"key":"R26-14-20210128","first-page":"303","article-title":"Lenalidomide for the treatment of resistant discoid lupus erythematosus","volume":"145","author":"Shah","year":"2009","journal-title":"Arch Dermatol Arch Dermatol"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaad.2008.11.904","article-title":"Efficacy and safety of pulsed dye laser treatment for cutaneous discoid lupus erythematosus","volume":"60","author":"Erceg","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp.2008.147892","article-title":"Thalidomide and sensory neurotoxicity: a neurophysiological study","volume":"79","author":"Zara","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/DAD.0b013e31818520e1","article-title":"Dermatomyositis: a clinicopathological study of 40 patients","volume":"31","author":"Smith","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R30-14-20210128","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaad.2008.05.034","article-title":"Dermatomyositis induced by drug therapy: a review of case reports","volume":"59","author":"Seidler","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.7.4.421","article-title":"Activity of certain drugs in inducing of inflammatory myopathies with cutaneous manifestations","volume":"7","author":"Dourmishev","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"R32-14-20210128","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1001\/archderm.144.10.1341","article-title":"Severe dermatomyositis triggered by interferon beta-1a therapy and associated with enhanced type I interferon signaling","volume":"144","author":"Somani","year":"2008","journal-title":"Arch Dermatol"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/ard.2007.077974","article-title":"A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies","volume":"67","author":"Dastmalchi","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R34-14-20210128","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1365-2133.2008.08711.x","article-title":"Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis","volume":"159","author":"Klein","year":"2008","journal-title":"Br J Dermatol"},{"key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/art.23313","article-title":"Alternative scoring of the Cutaneous Assessment Tool in juvenile dermatomyositis: results using abbreviated formats","volume":"59","author":"Huber","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1002\/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U","article-title":"Improvement in skin thickening in systemic sclerosis associated with improved survival","volume":"44","author":"Steen","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/1529-0131(200011)43:11<2445::AID-ANR11>3.0.CO;2-Q","article-title":"Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: high-dose versus low-dose penicillamine trial","volume":"43","author":"Clements","year":"2000","journal-title":"Arthritis Rheum"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/art.22747","article-title":"Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with antitopoisomerase I antibody","volume":"56","author":"Perera","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1002\/art.22721","article-title":"Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model","volume":"56","author":"Shand","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/rheumatology\/ken408","article-title":"Skin sclerosis is only of limited value to identify SSc patients with severe manifestations: an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register","volume":"48","author":"Hanitsch","year":"2009","journal-title":"Rheumatology (Oxf)"},{"key":"R41-14-20210128","first-page":"1194","article-title":"Systemic sclerosis: continuing progress in developing clinical measures of response","volume":"34","author":"Furst","year":"2007","journal-title":"J Rheumatol"},{"key":"R42-14-20210128","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/ard.2006.066530","article-title":"The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis","volume":"66","author":"Czirjak","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 5","key":"R43-14-20210128","doi-asserted-by":"crossref","first-page":"v44","DOI":"10.1093\/rheumatology\/ken309","article-title":"Skin involvement in systemic sclerosis","volume":"47","author":"Czirjak","year":"2008","journal-title":"Rheumatology (Oxf)"},{"key":"R44-14-20210128","first-page":"501","article-title":"Outcome measurements in scleroderma: results from a delphi exercise","volume":"34","author":"Gazi","year":"2007","journal-title":"J Rheumatol"},{"key":"R45-14-20210128","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1067\/mjd.2000.105165","article-title":"Ultraviolet A1 (340\u2013400 nm) phototherapy for scleroderma in systemic sclerosis","volume":"43","author":"Morita","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"R46-14-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1346-8138.2008.00417.x","article-title":"Ultrastructural changes induced in cutaneous collagen by ultraviolet-A1 and psoralen plus ultraviolet A therapy in systemic sclerosis","volume":"35","author":"Sakakibara","year":"2008","journal-title":"J Dermatol"},{"key":"R47-14-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0781.2009.00422.x","article-title":"Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis","volume":"25","author":"Rose","year":"2009","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"R48-14-20210128","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2133.2008.08452.x","article-title":"A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset","volume":"158","author":"Derk","year":"2008","journal-title":"Br J Dermatol"},{"key":"R49-14-20210128","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R50-14-20210128","first-page":"287","article-title":"A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis","volume":"25","author":"Vanthuyne","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"R52-14-20210128","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/art.24249","article-title":"B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis","volume":"60","author":"Lafyatis","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R53-14-20210128","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.24380","article-title":"Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial","volume":"60","author":"Khanna","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R54-14-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.22289","article-title":"Recombinant human antitransforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192","volume":"56","author":"Denton","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R55-14-20210128","first-page":"1830","article-title":"Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study","volume":"35","author":"Kawald","year":"2008","journal-title":"J Rheumatol"},{"key":"R56-14-20210128","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.24394","article-title":"Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients","volume":"61","author":"Sebastiani","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R57-14-20210128","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/art.24494","article-title":"Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis","volume":"60","author":"Hemmatazad","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R58-14-20210128","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jcp.21449","article-title":"Neutralizing monoclonal antibody to human connective tissue growth factor ameliorates transforming growth factor-beta-induced mouse fibrosis","volume":"216","author":"Ikawa","year":"2008","journal-title":"J Cell Physiol"},{"key":"R59-14-20210128","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/art.24221","article-title":"Molecular framework for response to imatinib mesylate in systemic sclerosis","volume":"60","author":"Chung","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R60-14-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/art.22314","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"56","author":"Distler","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R61-14-20210128","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s10067-005-0024-1","article-title":"Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy","volume":"25","author":"Rozin","year":"2006","journal-title":"Clin Rheumatol"},{"key":"R62-14-20210128","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.3899\/jrheum.080648","article-title":"Accelerated cutaneous nodulosis associated with aromatase inhibitor therapy in a patient with rheumatoid arthritis","volume":"36","author":"Chao","year":"2009","journal-title":"J Rheumatol"},{"key":"R63-14-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jaad.2004.07.023","article-title":"Rheumatoid arthritis: a review of the cutaneous manifestations","volume":"53","author":"Sayah","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R64-14-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/BOR.0b013e32831c5303","article-title":"Vasculitis in rheumatoid arthritis","volume":"21","author":"Turesson","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"R65-14-20210128","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2007.081679","article-title":"Antitumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis","volume":"67","author":"Puechal","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R66-14-20210128","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1001\/archderm.144.8.1075","article-title":"Therapeutic effect of argatroban on rheumatoid vasculitis with antiphosphatidylserine-prothrombin complex antibody","volume":"144","author":"Kawakami","year":"2008","journal-title":"Arch Dermatol"},{"key":"R67-14-20210128","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1001\/archderm.1994.01690100062010","article-title":"The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease","volume":"130","author":"Chu","year":"1994","journal-title":"Arch Dermatol"},{"key":"R68-14-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1468-3083.2007.02295.x","article-title":"Rheumatoid papules successfully treated with oral tacrolimus","volume":"22","author":"Kawachi","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R69-14-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1468-3083.2006.01826.x","article-title":"Infliximab therapy for interstitial granulomatous dermatitis","volume":"21","author":"Kreuter","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R70-14-20210128","first-page":"336","article-title":"Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept","volume":"81","author":"Hu","year":"2008","journal-title":"Cutis"},{"key":"R71-14-20210128","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch Dermatol"},{"key":"R72-14-20210128","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1001\/archderm.143.2.233","article-title":"The Yin and Yang of TNF-alpha inhibition","volume":"143","author":"Fiorentino","year":"2007","journal-title":"Arch Dermatol"},{"key":"R73-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00128071-200809010-00001","article-title":"Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients","volume":"9","author":"Wollina","year":"2008","journal-title":"Am J Clin Dermatol"},{"key":"R74-14-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-alpha inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e328333b9e2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:04:23Z","timestamp":1786039463000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201001000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":72,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e328333b9e2","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}